Keros Therapeutics, Inc. (KROS)
11.06
-0.02
(-0.23%)
USD |
NASDAQ |
Sep 01, 16:00
11.06
0.00 (0.00%)
After-Hours: 17:19
Keros Therapeutics Cash and Short Term Investments (Quarterly) : 257.61M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 257.61M |
| March 31, 2026 | 281.50M |
| December 31, 2025 | 287.42M |
| September 30, 2025 | 693.47M |
| June 30, 2025 | 690.22M |
| March 31, 2025 | 720.54M |
| December 31, 2024 | 559.93M |
| September 30, 2024 | 530.68M |
| June 30, 2024 | 405.86M |
| March 31, 2024 | 442.44M |
| December 31, 2023 | 331.15M |
| September 30, 2023 | 287.89M |
| June 30, 2023 | 322.03M |
| March 31, 2023 | 351.43M |
| Date | Value |
|---|---|
| December 31, 2022 | 279.05M |
| September 30, 2022 | 239.43M |
| June 30, 2022 | 215.62M |
| March 31, 2022 | 228.59M |
| December 31, 2021 | 230.04M |
| September 30, 2021 | 221.35M |
| June 30, 2021 | 237.11M |
| March 31, 2021 | 255.20M |
| December 31, 2020 | 265.88M |
| September 30, 2020 | 133.81M |
| June 30, 2020 | 144.69M |
| March 31, 2020 | 54.52M |
| December 31, 2019 | 7.02M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Incyte Corp. | 4.536B |
| Nurix Therapeutics, Inc. | 443.53M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |